Go to home page
INVESTIGATOR PROFILES

Paul J. Davis, M.D.

DIRECTOR
Ordway Research Institute

SENIOR SCIENTIST
Ordway Research Institute

SENIOR ASSOCIATE DEAN FOR CLINICAL RESEARCH AND PROFESSOR OF MEDICINE
Albany Medical College

PROFESSOR OF PHARMACY, Albany College of Pharmacy

CONTACT
Signal Transduction Laboratory
Phone: (518) 641-6410
Fax: (518) 641-6303
pdavis@ordwayresearch.org


Paul J. Davis, M.D.

Research Focus

The focus of the Davis Laboratory is defining the molecular basis of thyroid hormone actions initiated at the plasma membrane and in cytoplasm.  Acting via a plasma membrane receptor the laboratory has described on integrin αvβ3, thyroid hormone modifies the cellular actions of cytokines and growth factors, enhances angiogenesis and promotes the tumor cell proliferation. 

A collaboration with the laboratory of Dr. Shaker A. Mousa (Pharmacology Research Institute, Albany College of Pharmacy) has developed a broadly-based pharmaceutical platform that is based on the integrin receptor for thyroid hormone.  In this platform are reformulated thyroid hormone analogues that in low concentrations 1) inhibit cancer cell proliferation and tumor-associated angiogenesis, 2) restore chemosensitivity in chemotherapy-resistant cancer cells and 3) promote angiogenesis in ischemic tissues.

The laboratory also studies the mechanisms and cellular consequences of thyroid hormone-directed post-translational modifications (phosphorylation, acetylation) of nuclear hormone receptor proteins and thyroid hormone-modulated composition of nuclear enhanceosomes.  Thyroid hormone regulates these processes by mechanisms that originate outside the cell nucleus. 

Mechanisms are also studied of actions of estrogen and androgen that are initiated at the plasma membrane and in cytoplasm.  Actions of thyroid hormone may overlap or mimic actions of steroids.  For example, in the absence of estrogen, thyroid hormone in physiological concentrations can promote specific serine phosphorylation of nuclear estrogen receptor (ER)-α.  This action of thyroid hormone is initiated at the cell surface.

Dr. Davis is Thyroid Section Editor, Current Opinion in Endocrinology, Diabetes and Obesity, is Editor-in-Chief of Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry and is an Associate Editor of Endocrine Research.

Representative Publications (View)

  • Bergh JJ, Lin HY, Lansing L, Mohamed SN, Davis FB, Mousa S, Davis PJ.  2005.  Integrin αvβ3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis.  Endocrinology 146:2864-2871
  • Tang HY, Lin HY, Zhang S, Davis FB, Davis PJ.  2004.  Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor.  Endocrinology 145:3265-3272
  • Lin HY, Tang HY, Keating T, Wu YH, Shih A, Hammond D, Sun M, Hercbergs A, Davis FB, Davis PJ.  2008.  Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: both actions are integrin- and ERK-mediated.  Carcinogenesis 29:62-69
  • Davis FB, Tang HY, Shih A, Keating T, Lansing L, Hercbergs A, Fenstermaker RA, Mousa A, Mousa SA, Davis PJ, Lin HY.  2006.  Acting via a cell surface receptor, thyroid hormone is a growth factor glioma cells.  Cancer Res 66:7270-7275
  • Mousa SA, Bergh JJ, Dier E, Rebbaa A, O’Connor LJ, Yalcin M, Aljada A,. Dyskin S, Davis FB, Lin HY, Davis PJ.  2008.  Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.  Angiogenesis 11:183-190
  • Davis PJ, Leonard JL, Davis FB.  2008.  Mechanisms of nongenomic actions of thyroid hormone.  Front Neuroendocrinol 29:211-218
  • Mousa SA, O’Connor L, Davis FB, Davis PJ.  2006.  Proangiogenesis action of the thyroid hormone analog 3, 5-diiodothyropropionic acid (DITPA) is initiated at the cell surface and is integrin-mediated.  Endocrinology 147:1602-1607
  • Lin HY, Sun M, Tang HY, Lin C, Luidens MK, Mousa SA, Incerpi S, Drusano GL, Davis FB, Davis PJ.  2009.  L-Thyroxine vs. 3, 5, 3’-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase.  Am J Physiol, in press